The present invention discloses fused triterpene compounds, represented by the compounds of Formula I (as described herein), processes for their preparation, pharmaceutical compositions comprising the said compounds, their use as retinoid-related orphan receptors gamma (RORγ) modulators and/or interleukin-17 (IL-17) inhibitors and methods for their use in the treatment of a disease or a disorder mediated by RORγ and/or IL-17.
本发明公开了融合三萜化合物,由式I所表示的化合物,其制备方法,包括所述化合物的药物组合物,它们作为
视黄醇相关孤儿受体γ(RORγ)调节剂和/或白细胞介素-17(IL-17)
抑制剂的用途,以及它们在治疗由RORγ和/或IL-17介导的疾病或紊乱中的使用方法。